contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


rls-global-ab-publ-year-end-report-q4-2022

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

RLS Global

OCTOBER 1st - DECEMBER 31st (previous year in brackets)Net sales amounted to TSEK 291 (TSEK 219)Earnings before interest and taxes (EBIT) amounted to MSEK -7,9 (MSEK -7,8)Earnings per share ...

OCTOBER 1st - DECEMBER 31st (previous year in brackets)<ul><li>Net sales amounted to TSEK 291 (TSEK 219)</li><li>Earnings before interest and taxes (EBIT) amounted to MSEK -7,9 (MSEK -7,8)</li><li>Earnings per share after dilution at SEK -0,10 (SEK 0,09)</li><li>Cash flow from operating activities amounted to TSEK -5 779 (TSEK -4 887)</li><li>Liquid assets at the end of the period MSEK 20,5 ( MSEK 11,5)</li><li>Equity ratio was 83 % (75 %)</li></ul>JANUARY 1st - DECEMBER 31st (previous year in brackets)<ul><li>Net sales amounted to TSEK 1 198 (TSEK 653)</li><li>Earnings before interest and taxes (EBIT) amounted to MSEK -24,3 (MSEK 11,0)</li><li>Earnings per share after dilution at SEK -0,3 (SEK- 0,14)</li><li>Cash flow from operating activities amounted to TSEK -23 569 (TSEK -8 353)</li><li>Liquid assets at the end of the period MSEK 20,5 (MSEK 11,5)</li><li>Equity ratio was 83 % (75 %)</li></ul>SUMMARY OF EVENTS DURING FIRST QUARTER<ul><li>RLS Global's notified bodies perform quality audits (ISO 13485 and MDD) without remarks</li><li>Karin Fischer hands in her resignation</li><li>Convatec is taking over the agreements with Swedish customers</li><li>ChloraSolv is now delivered to the Convatec central warehouse on a regular basis</li><li>ChloraSolv is reimbursed in the Netherlands</li></ul>SUMMARY OF EVENTS DURING SECOND QUARTER<ul><li>Annual General Meeting is held May 19</li><li>RLS signs distribution contract for Middle East</li><li>RLS introduces ChloraSolv for the animal segment in Scandinavia by signing distribution contract with Swevet</li><li>ChloraSolv is approved for leg ulcers in Kuwait</li></ul>SUMMARY OF EVENTS DURING THIRD QUARTER<ul><li>An article regarding ChloraSolv is published in Journal of Wound Care</li><li>RLS Global strengthens its solvency by transforming a loan to share capital</li></ul>&nbsp;SUMMARY OF EVENTS DURING FOURTH QUARTER<ul><li>Björn Larsson starts as CEO</li><li>RLS carries out a new share issue (rights issue) and thereby raises SEK 26.8 million in cash and cash equivalents after issue costs</li><li>The Swedish Medicines Agency approves RLS' application for a clinical study regarding pressure ulcers</li><li>RLS takes part in the conference Wounds UK in Harrogate, England</li></ul>SUMMARY OF EVENTS AFTER FOURTH QUARTER<ul><li>An extra General Meeting is held February 9, 2023</li><li>Lars Johansson is elected as Chairman of the Board</li><li>RLS visits Arab Health, a global health conference in the Middle East and performs on-site distributor meetings and training sessions</li></ul>The Year-end Report Q4, 2022, is enclosed and is also available here.&nbsp;(<a href="https://rls.global/wp-content/uploads/2023/02/RLS_Global_Q4_2022_EN.pdf">https://rls.global/wp-content/uploads/2023/02/RLS_Global_Q4_2022_EN.pdf</a>)Publication This information was submitted for publication through the agency of the below contact person, at 08.30 CET on Feb 28th 2023.

Tilmeld dig vores nyhedsbrev - ingen konto nødvendig!